1-3 of 3
Danielle N. Yarde
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple Myeloma

Available to Purchase
Danielle N. Yarde, Vasco Oliveira, Linda Mathews, Xingyu Wang, Alejandro Villagra, David Boulware, Kenneth H. Shain, Lori A. Hazlehurst, Melissa Alsina, Dung-Tsa Chen, Amer A. Beg, William S. Dalton
Journal: Cancer Research
Cancer Res (2009) 69 (24): 9367–9375.
https://doi.org/10.1158/0008-5472.CAN-09-2616
Published: 14 December 2009
View articletitled, Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple Myeloma
Open the PDF for Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple Myeloma in another window
Includes: Supplementary data
Journal Articles

β1 Integrin Adhesion Enhances IL-6–Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation

Available to Purchase
Kenneth H. Shain, Danielle N. Yarde, Mark B. Meads, Mei Huang, Richard Jove, Lori A. Hazlehurst, William S. Dalton
Journal: Cancer Research
Cancer Res (2009) 69 (3): 1009–1015.
https://doi.org/10.1158/0008-5472.CAN-08-2419
Published: 29 January 2009
View articletitled, β1 Integrin Adhesion Enhances IL-6–Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation
Open the PDF for β1 Integrin Adhesion Enhances IL-6–Mediated STAT3 Signaling in Myeloma Cells: Implications for Microenvironment Influence on Tumor Survival and Proliferation in another window
Journal Articles

Fanconi anemia (FA)/BRCA pathway gene expression correlates with melphalan response and resistance and can be modified by the proteasome inhibitor bortezomib

Free
Danielle N. Yarde, Lori A. Hazlehurst, Natalie J. Parr, Qing Chen, William S. Dalton
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 554.
Published: 15 April 2006
View articletitled, Fanconi anemia (FA)/BRCA pathway gene expression correlates with melphalan response and resistance and can be modified by the proteasome inhibitor bortezomib